Novartis to buy Syncona’s Gyroscope Therapeutics for $1.5bn
LONDON, UK: Syncona Ltd has been reached to sell its portfolio company Gyroscope Therapeutics Holdings to Novartis for up to $1.5 billion on a cash...
Sanofi to invest up to $60 million in Gyroscope Therapeutics
LONDON, UK: Sanofi, a global biopharmaceutical company, has committed to invest up to $60 million in equity of Gyroscope Therapeutics Holdings. Gyroscope plans to use...